| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |